Vaccine for Porcine Reproductive and Respiratory Syndrome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064369
  • May 2021
  • Pharmaceuticals
  • 148 Pages
The global Vaccine for Porcine Reproductive and Respiratory Syndrome market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Vaccine for Porcine Reproductive and Respiratory Syndrome market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Vaccine for Porcine Reproductive and Respiratory Syndrome market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Vaccine for Porcine Reproductive and Respiratory Syndrome market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Boehringer-Ingelheim, MSD Animal Health, Sinopharm Group, Chengdu Tianbang Biological Products Co., Ltd, Qilu Animal Health, Komipharm, Bioveta, Phibro Animal Health, Zoetis, Agrovet
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Vaccine for Porcine Reproductive and Respiratory Syndrome market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Vaccine for Porcine Reproductive and Respiratory Syndrome market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Vaccine for Porcine Reproductive and Respiratory Syndrome market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Vaccine for Porcine Reproductive and Respiratory Syndrome market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market:
The Vaccine for Porcine Reproductive and Respiratory Syndrome market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Boehringer-Ingelheim, MSD Animal Health, Sinopharm Group, Chengdu Tianbang Biological Products Co., Ltd, Qilu Animal Health, Komipharm, Bioveta, Phibro Animal Health, Zoetis, Agrovet

Vaccine for Porcine Reproductive and Respiratory Syndrome Market Segment Analysis:
By Type
Live Vaccine
Inactivated Vaccine
Application
Government Tender
Marketing

Geographic Coverage for Vaccine for Porcine Reproductive and Respiratory Syndrome Market:
The market research report on global Vaccine for Porcine Reproductive and Respiratory Syndrome market offers complete analysis across various regions across the world. The Vaccine for Porcine Reproductive and Respiratory Syndrome market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Vaccine for Porcine Reproductive and Respiratory Syndrome market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Forecast
  • US
  • Canada
Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Vaccine for Porcine Reproductive and Respiratory Syndrome market report:
  • The report provides key trends of the global Vaccine for Porcine Reproductive and Respiratory Syndrome market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Vaccine for Porcine Reproductive and Respiratory Syndrome industry
  • The report covers all the recent developments of the Vaccine for Porcine Reproductive and Respiratory Syndrome market and helps to provide current industry updates
  • The report covers a detailed look over the global Vaccine for Porcine Reproductive and Respiratory Syndrome Industry and provides with significant actionable insights
  • The Vaccine for Porcine Reproductive and Respiratory Syndrome market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Vaccine for Porcine Reproductive and Respiratory Syndrome market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Vaccine for Porcine Reproductive and Respiratory Syndrome market
  • Comprehensive analysis of the Vaccine for Porcine Reproductive and Respiratory Syndrome market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Vaccine for Porcine Reproductive and Respiratory Syndrome market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Vaccine for Porcine Reproductive and Respiratory Syndrome market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Vaccine for Porcine Reproductive and Respiratory Syndrome market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Vaccine for Porcine Reproductive and Respiratory Syndrome market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Vaccine for Porcine Reproductive and Respiratory Syndrome market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Boehringer-Ingelheim
  • MSD Animal Health
  • Sinopharm Group
  • Chengdu Tianbang Biological Products Co., Ltd
  • Qilu Animal Health
  • Komipharm
  • Bioveta
  • Phibro Animal Health
  • Zoetis
  • Agrovet
  • Live Vaccine
  • Inactivated Vaccine
  • Government Tender
  • Marketing

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Snapshot
          2.1.1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market By Type,2019
               2.1.1.1.Live Vaccine
               2.1.1.2.Inactivated Vaccine
          2.1.2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market By Application,2019
               2.1.2.1.Government Tender
               2.1.2.2.Marketing
          2.1.3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market By End-use,2019
          2.1.4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market By Geography,2019

3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028

5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028

6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028

7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Analysis, 2018 – 2028 
          7.2.1. North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Analysis, 2018 – 2028 
          7.3.1.  Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Vaccine for Porcine Reproductive and Respiratory Syndrome Market Analysis, 2018 – 2028 
          7.6.1.  MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Vaccine for Porcine Reproductive and Respiratory Syndrome Providers
        8.4.1 Boehringer-Ingelheim
                8.4.1.1 Business Description
                8.4.1.2 Boehringer-Ingelheim Geographic Operations
                8.4.1.3 Boehringer-Ingelheim Financial Information
                8.4.1.4 Boehringer-Ingelheim Product Positions/Portfolio
                8.4.1.5 Boehringer-Ingelheim Key Developments
        8.4.2 MSD Animal Health
                8.4.2.1 Business Description
                8.4.2.2 MSD Animal Health Geographic Operations
                8.4.2.3 MSD Animal Health Financial Information
                8.4.2.4 MSD Animal Health Product Positions/Portfolio
                8.4.2.5 MSD Animal Health Key Developments
        8.4.3 Sinopharm Group
                8.4.3.1 Business Description
                8.4.3.2 Sinopharm Group Geographic Operations
                8.4.3.3 Sinopharm Group Financial Information
                8.4.3.4 Sinopharm Group Product Positions/Portfolio
                8.4.3.5 Sinopharm Group Key Developments
        8.4.4 Chengdu Tianbang Biological Products Co., Ltd
                8.4.4.1 Business Description
                8.4.4.2 Chengdu Tianbang Biological Products Co., Ltd Geographic Operations
                8.4.4.3 Chengdu Tianbang Biological Products Co., Ltd Financial Information
                8.4.4.4 Chengdu Tianbang Biological Products Co., Ltd Product Positions/Portfolio
                8.4.4.5 Chengdu Tianbang Biological Products Co., Ltd Key Developments
        8.4.5 Qilu Animal Health
                8.4.5.1 Business Description
                8.4.5.2 Qilu Animal Health Geographic Operations
                8.4.5.3 Qilu Animal Health Financial Information
                8.4.5.4 Qilu Animal Health Product Positions/Portfolio
                8.4.5.5 Qilu Animal Health Key Developments
        8.4.6 Komipharm
                8.4.6.1 Business Description
                8.4.6.2 Komipharm Geographic Operations
                8.4.6.3 Komipharm Financial Information
                8.4.6.4 Komipharm Product Positions/Portfolio
                8.4.6.5 Komipharm Key Developments
        8.4.7 Bioveta
                8.4.7.1 Business Description
                8.4.7.2 Bioveta Geographic Operations
                8.4.7.3 Bioveta Financial Information
                8.4.7.4 Bioveta Product Positions/Portfolio
                8.4.7.5 Bioveta Key Developments
        8.4.8 Phibro Animal Health
                8.4.8.1 Business Description
                8.4.8.2 Phibro Animal Health Geographic Operations
                8.4.8.3 Phibro Animal Health Financial Information
                8.4.8.4 Phibro Animal Health Product Positions/Portfolio
                8.4.8.5 Phibro Animal Health Key Developments
        8.4.9 Zoetis
                8.4.9.1 Business Description
                8.4.9.2 Zoetis Geographic Operations
                8.4.9.3 Zoetis Financial Information
                8.4.9.4 Zoetis Product Positions/Portfolio
                8.4.9.5 Zoetis Key Developments
        8.4.10 Agrovet
                8.4.10.1 Business Description
                8.4.10.2 Agrovet Geographic Operations
                8.4.10.3 Agrovet Financial Information
                8.4.10.4 Agrovet Product Positions/Portfolio
                8.4.10.5 Agrovet Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome: Market Segmentation 
FIG. 2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Vaccine for Porcine Reproductive and Respiratory Syndrome Providers, 2019
FIG. 11 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Vaccine for Porcine Reproductive and Respiratory Syndrome market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  North America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Country, 2018 – 2028
TABLE  Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Country, 2018 – 2028
TABLE  Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Country, 2018 – 2028
TABLE  MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment1, 2018 – 2028
TABLE  MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Segment2, 2018 – 2028
TABLE  MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, By Country, 2018 – 2028
TABLE  Boehringer-Ingelheim: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MSD Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sinopharm Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chengdu Tianbang Biological Products Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qilu Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Komipharm: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bioveta: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Phibro Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zoetis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agrovet: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market, By Geography, 2019 (US$ Mn)
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Vaccine for Porcine Reproductive and Respiratory Syndrome Providers, 2016
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Inactivated Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Marketing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Vaccine for Porcine Reproductive and Respiratory Syndrome Market Value, 2018 – 2028, (US$ Mn)